Homogeneous apoenzyme reactivation immunoassay for thyroxin-binding globulin in serum.

Area of Science:

• Clinical Chemistry
• Immunoassay Technology
• Endocrinology

Background:

• Thyroxin-binding globulin (TBG) is crucial for thyroid hormone transport.
• Accurate TBG measurement is essential for diagnosing thyroid disorders.
• Existing methods may have limitations in speed or automation.

Purpose of the Study:

• To evaluate the performance of the Ames Optimate, an automated immunoassay system for TBG.
• To assess the accuracy, precision, and efficiency of this novel TBG assay.

Main Methods:

• The Ames Optimate utilizes an apoenzyme reactivation immunoassay principle.
• It involves sequential reactions with labeled TBG, antiserum, and apoglucose oxidase.
• Glucose oxidase activity is measured colorimetrically.

Main Results:

• The assay requires 100 microL of sample, with results in 16 minutes and full assay completion in under 1 hour.
• It covers a clinically significant TBG range (2.5-55 mg/L) with a detection limit of 2.5 mg/L.
• High precision (CVs < 9% between-assay, < 6% within-assay), excellent analytical recovery (103-112%), and reagent stability (5 months) were observed.
• Strong correlation with radioimmunoassay (r=0.990) and good agreement for free thyroxin indices were confirmed.

Conclusions:

• The Ames Optimate is a rapid, automated, and accurate method for serum TBG determination.
• This system offers a reliable alternative to traditional radioimmunoassay for TBG analysis.
• The assay's performance supports its clinical utility in thyroid function testing.